QuantaMatrix: AMR testing technology from QuantaMatrix backed by research paper in Nature
The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods
Read full article »
QuantaMatrix develops and commercializes molecular and cellular based drugs for the treatment of Tuberculosis, infectious disease and cancer.
Read more